Login      Sign-Up  
Skip Navigation Links
Home
Laws
Bills
Sessions
House
Senate
Committees
Legislators
My Legis
2025 First Extraordinary Session
Other Sessions
Scroll up
Scroll down
2025 First Extraordinary Session
Other Sessions
Scroll up
Scroll down
House Committees
Senate Committees
Miscellaneous Committees
Scheduled Meetings
Scroll up
Scroll down
Representatives
Senators
Caucuses and Delegations
Scroll up
Scroll down

2017 Regular Session
HB436   by Representative Kirk Talbot      

DRUGS/PRESCRIPTION:  Requires drug manufacturers to provide information regarding prescription drug prices (EN NO IMPACT See Note)

Current Status:  Signed by the Governor - Act 220


Skip Navigation Links
TextExpand Text
AmendmentsExpand Amendments
DigestsExpand Digests
NotesExpand Notes
VotesExpand Votes
AuthorsExpand Authors
HB436 Act 220
HB436 Enrolled
HB436 Reengrossed
HB436 Engrossed
HB436 Original
Scroll up
Scroll down
House Floor Amendment #3351 Talbot Adopted
House Committee Amendment #2822 H&G Draft
House Committee Amendment #2454 H&W Adopted
House Committee Amendment #2288 H&W Draft
Scroll up
Scroll down
Resume Digest for HB436
Digest of HB436 Reengrossed
Digest of HB436 Engrossed
Digest of HB436 Original
Scroll up
Scroll down
Fiscal Note - HB436 Enrolled
Fiscal Note - HB436 ReEngrossed
Fiscal Note - HB436 Engrossed
Fiscal Note - HB436 Original
Scroll up
Scroll down
Senate Vote on HB 436 FINAL PASSAGE (#686)
House Vote on HB 436 FINAL PASSAGE (#444)
Scroll up
Scroll down
Kirk Talbot (primary)
Paul Hollis
H. Bernard LeBas
Dustin Miller
Helena Moreno
Major Thibaut
Scroll up
Scroll down

 Date   ChamberJournal
Page
Action sort history by ascending dates
06/14H  Effective date: 08/01/17.
06/14H  Signed by the Governor. Becomes Act No. 220.
06/05H  Sent to the Governor for executive approval.
06/05S52  Signed by the President of the Senate.
06/04H42  Enrolled and signed by the Speaker of the House.
06/02H41  Received from the Senate without amendments.
06/02S26  Rules suspended. Read by title, passed by a vote of 34 yeas and 0 nays, and ordered returned to the House. Motion to reconsider tabled.
06/01S32  Reported without Legislative Bureau amendments. Read by title and passed to third reading and final passage.
06/01S4  Read by title and referred to the Legislative Bureau.
05/31S7  Reported favorably.
05/30S12  Read second time by title and referred to the Committee on Health and Welfare.
05/25S6  Received in the Senate. Read first time by title and placed on the Calendar for a second reading.
05/24H19  Read third time by title, amended, roll called on final passage, yeas 100, nays 0. Finally passed, title adopted, ordered to the Senate.
05/18H  Scheduled for floor debate on 05/24/17.
05/17H17  Read by title, passed to 3rd reading.
05/17H17  Discharged from the Committee on House and Governmental Affairs.
05/17H17  Rules suspended.
05/17H  Involuntarily deferred in committee.
05/11H13  Read by title, amended, ordered engrossed, recommitted to the Committee on House and Governmental Affairs.
05/10H34  Reported with amendments (8-5).
04/10H52  Read by title, under the rules, referred to the Committee on Health and Welfare.
03/31H  Under the rules, provisionally referred to the Committee on Health and Welfare.
03/31H  Prefiled.




If you experience any technical difficulties navigating this website, contact the webmaster.
P.O. Box 94062 (900 North Third Street) Baton Rouge, Louisiana 70804-9062